nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—DAXX—adrenal gland cancer	0.0663	0.0884	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0495	0.066	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0391	0.0522	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—urine—adrenal gland cancer	0.0373	0.219	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Ca-dependent events—PRKACA—adrenal gland cancer	0.037	0.0494	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—adrenal gland cancer	0.0306	0.0408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.0284	0.0379	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PLC beta mediated events—PRKACA—adrenal gland cancer	0.0273	0.0364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—G-protein mediated events—PRKACA—adrenal gland cancer	0.0268	0.0357	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—CDC42—adrenal gland cancer	0.0255	0.034	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—adrenal cortex—adrenal gland cancer	0.0227	0.133	CbGeAlD
Fluocinolone Acetonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—adrenal gland cancer	0.0204	0.0272	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—pituitary gland—adrenal gland cancer	0.0183	0.107	CbGeAlD
Fluocinolone Acetonide—SERPINA6—pituitary gland—adrenal gland cancer	0.0182	0.107	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Endothelins—CDC42—adrenal gland cancer	0.0174	0.0232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—PRKACA—adrenal gland cancer	0.0167	0.0223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—CDC42—adrenal gland cancer	0.0167	0.0223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.0167	0.0222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—adrenal gland—adrenal gland cancer	0.0164	0.0959	CbGeAlD
Fluocinolone Acetonide—SERPINA6—adrenal gland—adrenal gland cancer	0.0163	0.0955	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0161	0.0215	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—adrenal gland cancer	0.0158	0.198	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.0155	0.0207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—adrenal gland cancer	0.0143	0.019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—GNAS—adrenal gland cancer	0.014	0.0187	CbGpPWpGaD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—adrenal gland cancer	0.0126	0.158	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—adrenal gland cancer	0.0125	0.157	CrCbGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—PRKACA—adrenal gland cancer	0.0117	0.0156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.0107	0.0143	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—adrenal gland cancer	0.0103	0.128	CrCbGaD
Fluocinolone Acetonide—NR3C1—adrenal cortex—adrenal gland cancer	0.00989	0.058	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00957	0.0128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—POMC—adrenal gland cancer	0.00913	0.0122	CbGpPWpGaD
Fluocinolone Acetonide—Prednisolone—ABCB1—adrenal gland cancer	0.0089	0.111	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00888	0.0119	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—ABCB1—adrenal gland cancer	0.00872	0.109	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.00848	0.0113	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—gonad—adrenal gland cancer	0.00819	0.048	CbGeAlD
Fluocinolone Acetonide—NR3C1—cardiac atrium—adrenal gland cancer	0.00818	0.048	CbGeAlD
Fluocinolone Acetonide—NR3C1—pituitary gland—adrenal gland cancer	0.00799	0.0468	CbGeAlD
Fluocinolone Acetonide—NR3C1—adrenal gland—adrenal gland cancer	0.00714	0.0418	CbGeAlD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00701	0.00935	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00675	0.00901	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.0067	0.00894	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.0064	0.00854	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—BRAF—adrenal gland cancer	0.00637	0.0085	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00636	0.00848	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.0062	0.00827	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00613	0.00818	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.00608	0.00812	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—adrenal gland cancer	0.00597	0.0747	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00579	0.00772	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—CTNNB1—adrenal gland cancer	0.0053	0.00708	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.00518	0.00692	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—ABCB1—adrenal gland cancer	0.00507	0.0635	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00499	0.00665	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00482	0.00643	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SPARC—adrenal gland cancer	0.00458	0.00611	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDHB—adrenal gland cancer	0.00447	0.00596	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—RB1—adrenal gland cancer	0.0043	0.00573	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00406	0.00542	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00388	0.00518	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKACA—adrenal gland cancer	0.00386	0.00516	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00367	0.00489	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00352	0.00469	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00347	0.00463	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—adrenal gland cancer	0.00345	0.0046	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00342	0.00456	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00328	0.00438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CDC42—adrenal gland cancer	0.00328	0.00437	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR5A1—adrenal gland cancer	0.00325	0.00434	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00318	0.00424	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF2—adrenal gland cancer	0.00316	0.00422	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CTNNB1—adrenal gland cancer	0.00316	0.00421	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GNAS—adrenal gland cancer	0.00313	0.00418	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00309	0.00412	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.00304	0.00405	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00299	0.00399	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—RRM1—adrenal gland cancer	0.00288	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDHD—adrenal gland cancer	0.00288	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00273	0.00364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.0026	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00222	0.00296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00218	0.00291	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MED12—adrenal gland cancer	0.00215	0.00287	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00205	0.00273	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MED12—adrenal gland cancer	0.00195	0.00261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00192	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00188	0.00251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00187	0.0025	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MEN1—adrenal gland cancer	0.00187	0.00249	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSHR—adrenal gland cancer	0.00183	0.00244	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNAS—adrenal gland cancer	0.0018	0.0024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MEN1—adrenal gland cancer	0.00172	0.00229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PRKACA—adrenal gland cancer	0.00157	0.00209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00153	0.00204	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00131	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNAS—adrenal gland cancer	0.00127	0.00169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—adrenal gland cancer	0.00125	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—adrenal gland cancer	0.00121	0.00161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDC42—adrenal gland cancer	0.00111	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—adrenal gland cancer	0.00107	0.00143	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNAS—adrenal gland cancer	0.00106	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00104	0.00138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—adrenal gland cancer	0.001	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—adrenal gland cancer	0.000892	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—adrenal gland cancer	0.000855	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BAD—adrenal gland cancer	0.000776	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—adrenal gland cancer	0.000715	0.000954	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—adrenal gland cancer	0.000706	0.000942	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000684	0.000913	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—adrenal gland cancer	0.000682	0.00091	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00051	0.000681	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—adrenal gland cancer	0.000404	0.000539	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—adrenal gland cancer	0.000339	0.000453	CbGpPWpGaD
